2008
DOI: 10.1097/ccm.0b013e3181841a91
|View full text |Cite
|
Sign up to set email alerts
|

Hypertonic saline up-regulates A3 adenosine receptor expression of activated neutrophils and increases acute lung injury after sepsis*

Abstract: Objective Hypertonic saline resuscitation reduces tissue damage by inhibiting polymorphonuclear neutrophils. Hypertonic saline triggers polymorphonuclear neutrophils to release adenosine triphosphate that is converted to adenosine, inhibiting polymorphonuclear neutrophils through A2a adenosine receptors. polymorphonuclear neutrophils also express A3 adenosine receptors that enhance polymorphonuclear neutrophils functions. Here we investigated whether A3 receptors may diminish the efficacy of hypertonic saline … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
26
0
7

Year Published

2008
2008
2016
2016

Publication Types

Select...
7
2

Relationship

3
6

Authors

Journals

citations
Cited by 31 publications
(36 citation statements)
references
References 32 publications
3
26
0
7
Order By: Relevance
“…Of particular interest is the fact that HS can block PMN activation and reduce host organ damage in animal models of shock (25, 27-31). Based on compelling preclinical evidence, the efficacy and immunomodulatory properties of HS resuscitation were recently tested in a large randomized clinical trial (32-33).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Of particular interest is the fact that HS can block PMN activation and reduce host organ damage in animal models of shock (25, 27-31). Based on compelling preclinical evidence, the efficacy and immunomodulatory properties of HS resuscitation were recently tested in a large randomized clinical trial (32-33).…”
Section: Discussionmentioning
confidence: 99%
“…In this multi-center study, which was carried out in major trauma centers across North America, a 250-ml bolus of 7.5% hypertonic saline (HS) with or without 6% dextran-70 (HSD) was administered to patients in a pre-hospital setting. The trial was stopped prematurely when it became evident that the mortality during the first day after admission was higher in the HS group than in the HSD group and in the control group that received an equal volume of normal saline (31). Nevertheless, the long-term mortality rates and clinical outcome measures did not significantly differ among the three treatment groups.…”
Section: Discussionmentioning
confidence: 99%
“…The antibodies were obtained from Santa Cruz Biotechnology (Santa Cruz, CA; A1 receptor), Abcam (Cambridge, MA; A2a receptor), EMD Millipore (Billerica, MA; A2b receptor), and Alpha Diagnostic International (San Antonio, TX; A3 receptor) and were used according to the manufacturers' directions. These antibodies have been extensively characterized and previously used by our group in several studies [3,[22][23][24][25].…”
Section: Quantitative Real-time Pcrmentioning
confidence: 99%
“…Recent work has demonstrated that hypertonic saline induces enhanced ATP release from PMNs that can result in PMN inhibition if A2a receptor expression predominates, but may exacerbate excessive PMN activation when A3 receptor expression is present (11-13). Furthermore, in a mouse model of sepsis, delayed resuscitation with HS actually increased A3 receptor expression and abolished the protective effects of hypertonic saline (11). This benefit was restored by the addition of an A3 receptor inhibitor (12).…”
Section: Introductionmentioning
confidence: 99%